Cancer Causes & Control

, Volume 21, Issue 12, pp 2223–2229 | Cite as

Dietary acrylamide intake and the risk of cancer among Finnish male smokers

  • T. Hirvonen
  • J. Kontto
  • M. Jestoi
  • L. Valsta
  • K. Peltonen
  • P. Pietinen
  • S. M. Virtanen
  • H. Sinkko
  • C. Kronberg-Kippilä
  • D. Albanes
  • J. Virtamo
Original paper



To assess the association between dietary acrylamide intake and the risk of cancer among male smokers.


The study consisted of 27,111 male smokers, aged 50–69 years, without history of cancer. They were participants of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study in Finland. The men completed a validated dietary questionnaire and a questionnaire on general background characteristics (including smoking habits) at baseline. Incident cases of cancer were identified through the national Finnish Cancer Registry.


During an average 10.2 year follow-up, 1,703 lung cancers, 799 prostate cancers, 365 urothelial cancers, 316 colorectal cancers, 224 stomach cancers, 192 pancreatic cancers, 184 renal cell cancers, and 175 lymphomas were diagnosed. Dietary acrylamide intake was positively associated with the risk of lung cancer; relative risk (RR) in the highest versus the lowest quintile in the multivariable-adjusted model was 1.18 ((95% confidence interval (CI) 1.01–1.38, p for trend 0.11). Other cancers were not associated with acrylamide intake.


High acrylamide intake is associated with increased risk of lung cancer but not with other cancers in male smokers.


Acrylamide intake Food Cancer Cohort studies 


  1. 1.
    Diekmann J, Wittig A, Stabbert R (2008) Gas chromatographic-mass spectrometric analysis of acrylamide and acetamide in cigarette mainstream smoke after on-column injection. J Chromatograph Sci 46:659–663Google Scholar
  2. 2.
    Eerola S, Hollebekkers K, Hallikainen A, Peltonen K (2007) Acrylamide levels in Finnish foodstuffs analysed with liquid chromatography tandem mass spectrometry. Mol Nutr Food Res 51:239–247CrossRefPubMedGoogle Scholar
  3. 3.
    Erdreich L, Friedman MA (2004) Epidemiologic evidence for assessing the carcinogenicity of acrylamide. Regul Toxicol Pharmacol 39:150–157CrossRefPubMedGoogle Scholar
  4. 4.
    Wirfält E, Paulson B, Törnqvist M, Axmon A, Hagmar L (2007) Associations between estimated acrylamide intake, and haemoglobin AA adducts in a sample from the Malmö Diet and cancer cohort. Eur J Clin Nutr 62:314–323CrossRefPubMedGoogle Scholar
  5. 5.
    Besaratinia A, Pfeifer GP (2007) A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis 28:519–528CrossRefPubMedGoogle Scholar
  6. 6.
    International Agency for Research on Cancer (1994) IARC monographs of the evaluation of carcinogenic risks to humans, vol 60. Some industrial chemicals. IARC, LyonGoogle Scholar
  7. 7.
    Ghanayem BI, McDaniel LP, Churchwell MI, Twaddle NC, Snyder R, Fennell TR, Doerge DR (2005) Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and haemoglobin adducts. Toxicol Sci 88:311–318CrossRefPubMedGoogle Scholar
  8. 8.
    Mucci LA, Adami HO, Wolk A (2006) Prospective study of dietary acrylamide and risk of colorectal cancer among women. Int J Cancer 118:169–173CrossRefPubMedGoogle Scholar
  9. 9.
    Pelucchi C, Galeone C, Levi F, Negri E, Franceschi S, Talamini R, Bosetti C, Giacosa A, La Vecchia C (2006) Dietary acrylamide and human cancer. Int J Cancer 2006 118:467–471CrossRefGoogle Scholar
  10. 10.
    Hogervorst JG, Schouten LJ, Konigs EJ, Goldbohm RA, van der Brandt PA (2007) A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol Biomarkers Prev 16:2304–2313CrossRefPubMedGoogle Scholar
  11. 11.
    Olesen PT, Olsen A, Frandsen H, Frederiksen K, Overvad K, Tjønneland A (2008) Acrylamide exposure and incidence of breast cancer among postmenopausal women in Danish Diet, cancer and health study. Int J Cancer 22:2094–2100CrossRefGoogle Scholar
  12. 12.
    Hogervorst JG, Schouten LJ, Konigs EJ, Goldbohm RA, van der Brandt PA (2008) Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer. Am J Clin Nutr 87:1428–1438PubMedGoogle Scholar
  13. 13.
    Hogervorst JG, Schouten LJ, Konigs EJ, Goldbohm RA, van den Brandt PA (2008) Dietary acrylamide intake is not associated with gastrointestinal cancer risk. J Nutr 138:2229–2236CrossRefPubMedGoogle Scholar
  14. 14.
    Hogervorst JG, Schouten LJ, Konigs EJ, Goldbohm RA, van der Brandt PA (2009) Lung cancer risk in relation to dietary acrylamide intake. J Natl Cancer Inst 101:651–662CrossRefPubMedGoogle Scholar
  15. 15.
    Larsson SC, Akeson A, Wolk A (2009) Long-term dietary acrylamide intake and risk of epithelial ovarian cancer in a prospective cohort of Swedish women. Cancer Epidemiol Biomarkers Prev 18:994–997CrossRefPubMedGoogle Scholar
  16. 16.
    Larsson SC, Akesson A, Wolk A (2009) Long-term dietary acrylamide intake and breast cancer risk in a prospective cohort of Swedish women. Am J Epidemiol 169:376–381CrossRefPubMedGoogle Scholar
  17. 17.
    Larsson SC, Håkansson N, Akesson A, Wolk A (2009) Long-term dietary acrylamide intake and risk of endometrial cancer in a prospective cohort of Swedish women. Int J Cancer 124:1196–1199CrossRefPubMedGoogle Scholar
  18. 18.
    Wilson KM, Bälter K, Adami HO, Grönberg H, Vikström AC, Paulson B, Törnqvist M, Mucci LA (2009) Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study. Int J Cancer 124:2384–2390CrossRefPubMedGoogle Scholar
  19. 19.
    Wilson KM, Mucci LA, Cho E, Hunter DJ, Chen WY, Willett WC (2009) Dietary acrylamide intake and risk of premenopausal breast cancer. Am J Epidemiol 169:954–961CrossRefPubMedGoogle Scholar
  20. 20.
    Hogervorst JG, Schouten LJ, Konigs EJ, Goldbohm RA, van der Brandt PA (2009) Dietary acrylamide intake and brain cancer risk. Cancer Epidemiol Biomarkers Prev 18:1663–1666CrossRefPubMedGoogle Scholar
  21. 21.
    Pedersen GS, Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van der Brandt PA (2010) Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk. Breast Cancer Res Treat 122:199–210CrossRefPubMedGoogle Scholar
  22. 22.
    Wilson KM, Mucci LA, Rosner BA, Willett WC A prospective study of dietary acrylamide intake and the risk of breast, endometrial, and ovarian cancers. Cancer Epidemiol Biomarkers Prev. 2010 Aug 6 (Epub ahead of print)Google Scholar
  23. 23.
    Mucci LA, Lindblad P, Steineck G, Adami HO (2004) Dietary acrylamide and risk of renal cell cancer. Int J Cancer 109:774–776CrossRefPubMedGoogle Scholar
  24. 24.
    Mucci LA, Dickman PW, Steineck G, Adami HO, Augustsson K (2003) Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer 88:84–89CrossRefPubMedGoogle Scholar
  25. 25.
    Larsson SC, Akesson A, Wolk A (2009) Dietary acrylamide intake and prostate cancer risk in a prospective cohort of Swedish men. Cancer Epidemiol Biomarkers Prev 18:1939–1941CrossRefPubMedGoogle Scholar
  26. 26.
    The ATBC Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4:1–10CrossRefGoogle Scholar
  27. 27.
    Pietinen P, Hartman AM, Haapa E, Räsänen L, Haapakoski J, Palmgren J, Albanes D, Virtamo J, Huttunen JK (1988) Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 128:655–666PubMedGoogle Scholar
  28. 28.
    Svensson K, Abrahamsson L, Becker W, Glynn A, Hellenäs K-E, Lind Y, Rosén J (2003) Dietary intake of acrylamide in Sweden. Food Chem Toxicol 41:1581–1586CrossRefPubMedGoogle Scholar
  29. 29.
    Konings EJM, Baars AJ, van Klaveren JD, Spanjer MC, Rensen PM, Hiemstra M, van Kooij JA, Peters PWJ (2003) Acrylamide exposure from foods of the Dutch population and an assessment of the consequent risks. Food Chem Toxicol 41:1569–1579CrossRefPubMedGoogle Scholar
  30. 30.
    Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J (2002) The Finnish Cancer Registry as follow-up source of a large trial cohort–accuracy and delay. Acta Oncol 41:381–388CrossRefPubMedGoogle Scholar
  31. 31.
    Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analysis. Am J Epidemiol 124:17–27PubMedGoogle Scholar
  32. 32.
    Parzefall W (2008) Minireview on the toxicity of dietary acrylamide. Food Chem Toxicol 46:1360–1364CrossRefPubMedGoogle Scholar
  33. 33.
    European Food Safety Authority (2009) Results on the monitoring of acrylamide levels in food: a report of the data collection and exposure unit in response to a request from the European commission. EFSA Scientific Rep 285:1–26Google Scholar
  34. 34.
    Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics–chemistry, bioavailability and effects on health. Nat Prod Rep 26:1001–1043CrossRefPubMedGoogle Scholar
  35. 35.
    Jeong HJ, Lee JR, Jeong JB, Park JH, Cheong YK, de Lumen BO (2009) The cancer preventive seed peptide lunasin from rye is bioavailable and bioactive. Nutr Cancer 61:680–686CrossRefPubMedGoogle Scholar
  36. 36.
    Wenzl T, Lachenmeier DW, Gökmen V (2007) Analysis of heat-induced contaminants (acrylamide, choloropropanols and furan) in carbohydrate-rich foods. Anal Bioanal Chem 389:119–137CrossRefPubMedGoogle Scholar
  37. 37.
    Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P (2001) Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control 12:789–796CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • T. Hirvonen
    • 1
  • J. Kontto
    • 2
  • M. Jestoi
    • 3
  • L. Valsta
    • 4
  • K. Peltonen
    • 3
  • P. Pietinen
    • 2
  • S. M. Virtanen
    • 4
  • H. Sinkko
    • 4
  • C. Kronberg-Kippilä
    • 4
  • D. Albanes
    • 5
  • J. Virtamo
    • 2
  1. 1.Finnish Food Safety Authority, Risk Assessment UnitHelsinkiFinland
  2. 2.National Institute for Health and Welfare (THL), Department of Chronic Disease PreventionHelsinkiFinland
  3. 3.Finnish Food Safety Authority, Research Department, Unit of Chemistry and ToxicologyHelsinkiFinland
  4. 4.National Institute for Health and Welfare (THL), Department of Lifestyle and ParticipationHelsinkiFinland
  5. 5.National Cancer Institute, Division of Cancer Epidemiology and Genetics, Nutritional Epidemiology BranchBethesdaUSA

Personalised recommendations